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Background
Occult myocardial scar is known to be a predictive factor of poor prognosis in the diabetes patients. The purposes of this study are to evaluate through an exploratory substudy the accuracy of delayed-enhancement CT (DE-CT) for detecting occult myocardial scars (OMS) and to evaluate the transmurality of OMS using DE-CT compared with delayed enhancement MRI (DE-MRI) in asymptomatic patients with type 2 diabetes.
Methods
In this prospective, multicenter, and open-label study, 347 patients with type 2 DM were included with 2 or more risk factors of coronary artery disease. DE-MRI and DE-CT were respectively performed with Gadoterate Meglumine (Dotarem ® ) and Iobitridol (Xenetix ® 350) on 167 patients. Image quality of DE-CT was evaluated using 4-grading system, good, adequate, poor and null. The prevalence and the transmurality of OMS on both DE-MRI and DE-CT at patient level and segment level were evaluated. The sensitivity, specificity, positive and negative predictive values of DE-CT for detecting OMS was evaluated in comparison with DE-MRI both at patient and segment level. The transmurality of OMS in DE-CT and DE-MRI for each scar was assessed in terms of over-or underestimation of DE-CT using six grade system, none, 1-25%, 26-50%, 51-75%, and 76-99%, and 100% at segment level.
Results
The image quality of DE-CT was good and adequate in 165 (98.8%) patients. The OMS was detected in 12 
